CAESAR is developing QSAR models for five endpoints (link a pag 1):

• bioconcentration factor
• skin sensitization
• mutagenicity
• carcinogenicity
• developmental reprotoxicity

The model adequacy for REACH

CAESAR’s QSAR models have been developed addressing REACH legislation. We put great care in the quality of the data used to build up the model. CAESAR’s models have been validated with a range of approached. They are transparent and reproducible. We checked the models against the OECD principles (more...).

The model procedure

The procedure has been designed to maximise the model performances, reproducibility and transparency (more...).

The model availability

Models will be freely available at the end of the project (March 2009). In some cases the user has to employ other programs for calculation.